头颈部淋巴瘤的诊疗新进展  

New advancement in diagnosis and treatment of head and neck lymphoma

作　　者：王小琴[1] 刘良发[2] 

机构地区：[1]首都医科大学附属良乡教学医院耳鼻咽喉科,北京102401 [2]首都医科大学附属北京友谊医院耳鼻咽喉头颈外科

出　　处：《临床耳鼻咽喉头颈外科杂志》2016年第22期1819-1822,共4页Journal of Clinical Otorhinolaryngology Head And Neck Surgery

摘　　要：淋巴瘤包括霍奇金淋巴瘤（Hodgkins lymphoma,HL）与非霍奇金淋巴瘤（non-Hodgkins lymphoma,NHL）,它是发生于淋巴结以及结外淋巴组织的一种恶性肿瘤。头颈部有丰富的淋巴组织以及富含淋巴组织的器官,据统计,头颈部恶性淋巴瘤（malignant lymphoma,ML）占头颈部所有恶性肿瘤的5%左右,是淋巴瘤第二大的好发部位[1-2]。随着人们生活方式的改变,淋巴瘤的发病率越来越高。近年来淋巴瘤的检出率也逐渐升高。Malignant lymphomas are common malignant neoplastic of lymphatic hematopoietic system,and there are different clinic manifestation in different sites.Malignant lymphomas in the head and neck have characteristics in clinic features,pathologic types and the most common locations.This review is about the role of different clinic manifestation,pathologic types and the International Prognostic Idex（IPI）in the evaluation of prognosis in the head and neck lymphoma.

关 键 词：头颈部 淋巴瘤 病理分型 预后 

分 类 号：R733.4[医药卫生—肿瘤]